Vycor Medical (VYCO) Change in Receivables (2010 - 2026)
Vycor Medical's (VYCO) quarterly Change in Receivables came in at $8407.0 in Q2 2026, up 131.43% year-over-year from $3632.6 in Q2 2025, and up 150.92% quarter-over-quarter from -$16510.0 in Q1 2026.
Powered by 
Analysis
Vycor Medical (VYCO) Change in Receivables (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has reported Change in Receivables for 17 consecutive years, with $8407.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Change in Receivables rose 131.43% year-over-year to $8407.0 in Q2 2026; TTM through Jun 2026 was $10810.0, a 120.95% increase from a year earlier, with the FY2025 full-year figure at -$23678.0, down 170.88% from the prior year.
- Change in Receivables was $8407.0 for Q2 2026 at Vycor Medical, up from -$16510.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $126074.0 in Q3 2025 and troughed at -$107161.0 in Q4 2025.
- A 5-year average of $5042.1 and a median of -$4503.0 in 2024 frame the typical range for Change in Receivables.
- The widest YoY moves for Change in Receivables: up 909.93% in 2025, down 1733.55% in 2025.
- Over 5 years, Change in Receivables stood at -$24354.0 in 2022, then plunged by 64.39% to -$40035.0 in 2023, then soared by 116.39% to $6560.0 in 2024, then slumped by 1733.55% to -$107161.0 in 2025, then soared by 107.85% to $8407.0 in 2026.
- The last three Change in Receivables figures came in at $8407.0 (Q2 2026), -$16510.0 (Q1 2026), and -$107161.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 74.90 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -224.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 177.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 46.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 10.20 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 172.10 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Vycor Medical | 2.34 Mn | 2.18 Mn | 344,445.00 | 8,407.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8,407.00 |
| Mar 31, 2026 | -16,510.00 |
| Dec 31, 2025 | -107,161.00 |
| Sep 30, 2025 | 126,074.00 |
| Jun 30, 2025 | -26,745.00 |
| Mar 31, 2025 | -15,846.00 |
| Dec 31, 2024 | 6,560.00 |
| Sep 30, 2024 | -15,566.00 |
| Jun 30, 2024 | 8,707.00 |
| Mar 31, 2024 | 33,703.00 |
| Dec 31, 2023 | -40,035.00 |
| Sep 30, 2023 | -27,284.00 |
| Jun 30, 2023 | 104,653.00 |
| Mar 31, 2023 | 21,693.00 |
| Dec 31, 2022 | -24,354.00 |
| Sep 30, 2022 | -31,898.00 |
| Jun 30, 2022 | 50,674.00 |
| Mar 31, 2022 | 35,686.00 |
| Dec 31, 2021 | -50,788.00 |
| Sep 30, 2021 | -28,203.00 |